Ratings Thai NVDR Co., Ltd.

Equities

End-of-day quote Thailand S.E. Other stock markets 03:30:00 28/05/2024 am IST			5-day change	1st Jan Change
43 ^THB	-1.15%		+10.97%	+2.38%

24/05	Consortium of buyers agreed to acquire 5% stake in The Klinique Medical Clinic Public Company Limited from Ekachai Medical Care Public Company Limited for THB 430 million.	CI
14/05	The Klinique Medical Clinic Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

The prospective high growth for the next fiscal years is among the main assets of the company
Analysts covering this company mostly recommend stock overweighting or purchase.

With a 2024 P/E ratio at 25.9 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
The company appears highly valued given the size of its balance sheet.

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
THAI NVDR CO., LTD.	+2.38%	262M	-	-
AIER EYE HOSPITAL GROUP CO., LTD.	-23.01%	15.84B		B+
BANGKOK DUSIT MEDICAL SERVICES	+1.80%	12.38B		B
IHH HEALTHCARE	+2.82%	11.79B		B+
APOLLO HOSPITALS ENTERPRISE LIMITED	+3.51%	10.27B		B+
ENCOMPASS HEALTH CORPORATION	+25.10%	8.51B		B
RAMSAY HEALTH CARE LIMITED	-8.80%	7.54B		A-
THE ENSIGN GROUP, INC.	+5.99%	6.78B		B-
MOUWASAT MEDICAL SERVICES COMPANY	-2.50%	5.96B		D
DALLAH HEALTHCARE COMPANY	-4.54%	4.28B		-

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality